AAAAAA

   
Results: 1-25 | 26-48
Results: 1-25/48
RANDOMIZED STUDY OF PACLITAXEL-CISPLATIN VERSUS CISPLATIN-TENIPOSIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: GIACCONE G SPLINTER TAW DEBRUYNE C KHO GS LIANES P VANZANDWIJK N PENNUCCI MC SCAGLIOTTI G VANMEERBEECK J VANHOESEL Q CURRAN D SAHMOUD T POSTMUS PE
Citation: G. Giaccone et al., RANDOMIZED STUDY OF PACLITAXEL-CISPLATIN VERSUS CISPLATIN-TENIPOSIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 16(6), 1998, pp. 2133-2141
EVALUATION OF ANTIANDROGEN THERAPY IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA - RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENTOF CANCER MULTICENTRIC DOUBLE-BLIND TRIAL
Authors: GRIMALDI C BLEIBERG H GAY F MESSNER M ROUGIER P KOK TC CIRERA L CERVANTES A DEGREVE J PAILLOT B BUSET M NITTI D SAHMOUD T DUEZ N WILS J
Citation: C. Grimaldi et al., EVALUATION OF ANTIANDROGEN THERAPY IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA - RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENTOF CANCER MULTICENTRIC DOUBLE-BLIND TRIAL, Journal of clinical oncology, 16(2), 1998, pp. 411-417
ADEQUATE NUMBER OF PATIENTS ARE NEEDED TO EVALUATE ADJUVANT TREATMENTIN GASTRIC-CANCER
Authors: BLEIBERG H SAHMOUD T DILEO A CUNNINGHAM D ROUGIER P
Citation: H. Bleiberg et al., ADEQUATE NUMBER OF PATIENTS ARE NEEDED TO EVALUATE ADJUVANT TREATMENTIN GASTRIC-CANCER, Journal of clinical oncology, 16(11), 1998, pp. 3714-3714
PROGNOSTIC FACTORS IN PATIENTS WITH PLEURAL MESOTHELIOMA - THE ON-FOR-RESEARCH-AND-TREATMENT-OF-CANCER-EXPERIENCE
Authors: CURRAN D SAHMOUD T THERASSE P VANMEERBEECK J POSTMUS PE GIACCONE G
Citation: D. Curran et al., PROGNOSTIC FACTORS IN PATIENTS WITH PLEURAL MESOTHELIOMA - THE ON-FOR-RESEARCH-AND-TREATMENT-OF-CANCER-EXPERIENCE, Journal of clinical oncology, 16(1), 1998, pp. 145-152
EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG
Authors: WILS J SAHMOUD T SOBRERO A BLEIBERG H AHMEDZAI S BLAZEBY J BLIJHAM G CONROY T CUNNINGHAM D CURRAN D DIAZRUBIO E DUCREUX M EVANS J GLIMELIUS B HUTCHINSON G KERR D KIEBERT G KOHNE H LABIANCA R LANGENDIJK R NITTI D NORDLINGER B ROUGIER P SCHEITHAUER W SCHMOLL HJ VANCUTSEM E WAGENER T WILKE J MARINUS A THERASSE P
Citation: J. Wils et al., EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG, Tumori, 84(3), 1998, pp. 335-347
BRAIN-ONLY METASTASES OF SMALL-CELL LUNG-CANCER - EFFICACY OF WHOLE-BRAIN RADIOTHERAPY - AN EORTC PHASE-II STUDY
Authors: POSTMUS PE HAAXMAREICHE H GREGOR A GROEN HJM LEWINSKI T SCOLARD T KIRKPATRICK A CURRAN D SAHMOUD T GIACCONE G
Citation: Pe. Postmus et al., BRAIN-ONLY METASTASES OF SMALL-CELL LUNG-CANCER - EFFICACY OF WHOLE-BRAIN RADIOTHERAPY - AN EORTC PHASE-II STUDY, Radiotherapy and oncology, 46(1), 1998, pp. 29-32
RESPONSE OF RECURRENT GLIOBLASTOMA AND ANAPLASTIC ASTROCYTOMA TO DIBROMODULCITOL, BCNU AND PROCARBAZINE - A PHASE-II STUDY
Authors: HILDEBRAND J DEWITTE O SAHMOUD T
Citation: J. Hildebrand et al., RESPONSE OF RECURRENT GLIOBLASTOMA AND ANAPLASTIC ASTROCYTOMA TO DIBROMODULCITOL, BCNU AND PROCARBAZINE - A PHASE-II STUDY, Journal of neuro-oncology, 37(2), 1998, pp. 155-160
ADJUVANT PORTAL-VEIN INFUSION OF FLUOROURACIL AND HEPARIN IN COLORECTAL-CANCER - A RANDOMIZED TRIAL
Authors: ROUGIER P SAHMOUD T NITTI D CURRAN D DOCI R DEWAELE B NAKAJIMA T RAUSCHECKER H LABIANCA R PECTOR JC MARSONI S APOLONE G LASSER P COUVREUR ML WILS J
Citation: P. Rougier et al., ADJUVANT PORTAL-VEIN INFUSION OF FLUOROURACIL AND HEPARIN IN COLORECTAL-CANCER - A RANDOMIZED TRIAL, Lancet, 351(9117), 1998, pp. 1677-1681
PHASE-II STUDY OF WEEKLY 4'-EPIDOXORUBICIN IN PATIENTS WITH METASTATIC ADENOCARCINOMA OF THE CERVIX - AN EORTC GYNECOLOGICAL CANCER COOPERATIVE GROUP-STUDY
Authors: VANDERBURG MEL BOLIS G BAKKER PJM CURRAN D SAHMOUD T VERMORKEN JB
Citation: Mel. Vanderburg et al., PHASE-II STUDY OF WEEKLY 4'-EPIDOXORUBICIN IN PATIENTS WITH METASTATIC ADENOCARCINOMA OF THE CERVIX - AN EORTC GYNECOLOGICAL CANCER COOPERATIVE GROUP-STUDY, European journal of cancer, 33(9), 1997, pp. 1513-1515
FINAL RESULTS OF A PHASE-III CLINICAL-TRIAL ON ADJUVANT INTRAPORTAL INFUSION WITH HEPARIN AND 5-FLUOROURACIL (5-FU) IN RESECTABLE COLON-CANCER (EORTC GITCCG 1983-1987)
Authors: NITTI D WILS J SAHMOUD T CURRAN D COUVREUR ML LISE M RAUSCHECKER H DOSSANTOS JG STREMMEL W ROELOFSEN F
Citation: D. Nitti et al., FINAL RESULTS OF A PHASE-III CLINICAL-TRIAL ON ADJUVANT INTRAPORTAL INFUSION WITH HEPARIN AND 5-FLUOROURACIL (5-FU) IN RESECTABLE COLON-CANCER (EORTC GITCCG 1983-1987), European journal of cancer, 33(8), 1997, pp. 1209-1215
RANDOMIZED PHASE-II STUDY OF CISPLATIN AND 5-FLUOROURACIL (5-FU) VERSUS CISPLATIN ALONE IN ADVANCED SQUAMOUS-CELL ESOPHAGEAL CANCER
Authors: BLEIBERG H CONROY T PAILLOT B LACAVE AJ BLIJHAM G JACOB JH BEDENNE L NAMER M DEBESI P GAY F COLLETTE L SAHMOUD T
Citation: H. Bleiberg et al., RANDOMIZED PHASE-II STUDY OF CISPLATIN AND 5-FLUOROURACIL (5-FU) VERSUS CISPLATIN ALONE IN ADVANCED SQUAMOUS-CELL ESOPHAGEAL CANCER, European journal of cancer, 33(8), 1997, pp. 1216-1220
THE IDENTIFICATION OF HIGH-RISK PATIENTS WITH METASTATIC COLORECTAL-CANCER
Authors: SAHMOUD T GRABOWSKA E BLIJHAM G KOHNE CH COUVREUR ML CURRAN D WILS J
Citation: T. Sahmoud et al., THE IDENTIFICATION OF HIGH-RISK PATIENTS WITH METASTATIC COLORECTAL-CANCER, European journal of cancer, 33, 1997, pp. 741-741
RADIOTHERAPY AND 5-FU AFTER CURATIVE RESECTION FOR THE CANCER OF THE PANCREAS AND PERI-AMPULLARY REGION - A PHASE-III TRIAL OF THE EORTC GITCCG
Authors: KLINKENBIJL JHG SAHMOUD T VANPEL R COUVREUR ML VEENHOF CHN ARNAUD JP HENNIPMAN A WILS J JEEKEL J
Citation: Jhg. Klinkenbijl et al., RADIOTHERAPY AND 5-FU AFTER CURATIVE RESECTION FOR THE CANCER OF THE PANCREAS AND PERI-AMPULLARY REGION - A PHASE-III TRIAL OF THE EORTC GITCCG, European journal of cancer, 33, 1997, pp. 1239-1239
ETOPOSIDE IN MALIGNANT PLEURAL MESOTHELIOMA - 2 PHASE-II TRIALS OF THE EORTC LUNG-CANCER COOPERATIVE GROUP
Authors: SAHMOUD T POSTMUS PE VANPOTTELSBERGHE C MATTSON K TAMMILEHTO L SPLINTER TAW PLANTING AST SUTEDJA T VANPAWEL J VANZANDWIJK N BAAS P ROOZENDAAL KJ SCHRIJVER M KIRKPATRICK A VANGLABBEKE M ARDIZZONI A GIACCONE G
Citation: T. Sahmoud et al., ETOPOSIDE IN MALIGNANT PLEURAL MESOTHELIOMA - 2 PHASE-II TRIALS OF THE EORTC LUNG-CANCER COOPERATIVE GROUP, European journal of cancer, 33(13), 1997, pp. 2211-2215
ROLE OF RECOMBINANT INTERFERON-GAMMA MAINTENANCE IN RESPONDING PATIENTS WITH SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY OF THE EORTC LUNG-CANCER COOPERATIVE GROUP
Authors: VANZANDWIJK N GROEN HJM POSTMUS PE BURGHOUTS JTW TENVELDE GPM ARDIZZONI A SMITH IE BAAS P SAHMOUD T KIRKPATRICK A DALESIO O GIACCONE G
Citation: N. Vanzandwijk et al., ROLE OF RECOMBINANT INTERFERON-GAMMA MAINTENANCE IN RESPONDING PATIENTS WITH SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY OF THE EORTC LUNG-CANCER COOPERATIVE GROUP, European journal of cancer, 33(11), 1997, pp. 1759-1766
RANDOMIZED TRIAL OF ALTERNATING VERSUS SEQUENTIAL RADIOTHERAPY CHEMOTHERAPY IN LIMITED-DISEASE PATIENTS WITH SMALL-CELL LUNG-CANCER - A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER LUNG-CANCER COOPERATIVE GROUP-STUDY/
Authors: GREGOR A DRINGS P BURGHOUTS J POSTMUS PE MORGAN D SAHMOUD T KIRKPATRICK A DALESIO O GIACCONE G
Citation: A. Gregor et al., RANDOMIZED TRIAL OF ALTERNATING VERSUS SEQUENTIAL RADIOTHERAPY CHEMOTHERAPY IN LIMITED-DISEASE PATIENTS WITH SMALL-CELL LUNG-CANCER - A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER LUNG-CANCER COOPERATIVE GROUP-STUDY/, Journal of clinical oncology, 15(8), 1997, pp. 2840-2849
CHEMORADIOTHERAPY FOLLOWED BY SURGERY COMPARED WITH SURGERY ALONE IN SQUAMOUS-CELL CANCER OF THE ESOPHAGUS
Authors: BOSSET JF GIGNOUX M TRIBOULET JP TIRET E MANTION G ELIAS D LOZACH P OLLIER JC PAVY JJ MERCIER M SAHMOUD T
Citation: Jf. Bosset et al., CHEMORADIOTHERAPY FOLLOWED BY SURGERY COMPARED WITH SURGERY ALONE IN SQUAMOUS-CELL CANCER OF THE ESOPHAGUS, The New England journal of medicine, 337(3), 1997, pp. 161-167
MESALAZINE AS A MAINTENANCE TREATMENT IN CROHNS-DISEASE - IS IT THE LONG AWAITED SOLUTION
Authors: SAHMOUD T MARY JY
Citation: T. Sahmoud et Jy. Mary, MESALAZINE AS A MAINTENANCE TREATMENT IN CROHNS-DISEASE - IS IT THE LONG AWAITED SOLUTION, Gut, 40(2), 1997, pp. 284-285
RADICAL SURGERY AND POSTOPERATIVE RADIOTHERAPY AS COMBINED TREATMENT IN RECTAL-CANCER - FINAL RESULTS OF A PHASE-III STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER
Authors: ARNAUD JP NORDLINGER B BOSSET JF BOES GH SAHMOUD T SCHLAG PM PENE F
Citation: Jp. Arnaud et al., RADICAL SURGERY AND POSTOPERATIVE RADIOTHERAPY AS COMBINED TREATMENT IN RECTAL-CANCER - FINAL RESULTS OF A PHASE-III STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER, British Journal of Surgery, 84(3), 1997, pp. 352-357
LARYNX PRESERVATION IN PYRIFORM SINUS CANCER - PRELIMINARY-RESULTS OFA EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER PHASE-III TRIAL
Authors: LEFEBVRE JL CHEVALIER D LUBOINSKI B KIRKPATRICK A COLLETTE L SAHMOUD T
Citation: Jl. Lefebvre et al., LARYNX PRESERVATION IN PYRIFORM SINUS CANCER - PRELIMINARY-RESULTS OFA EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER PHASE-III TRIAL, Journal of the National Cancer Institute, 88(13), 1996, pp. 890-899
STANDARD VERSUS ALTERNATING NON-CROSS-RESISTANT CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER - AN EORTC PHASE-III TRIAL
Authors: POSTMUS PE SCAGLIOTTI G GROEN HJM GOZZELINO F BURGHOUTS JTW CURRAN D SAHMOUD T KIRKPATRICK A GIACCONE G SPLINTER TAW
Citation: Pe. Postmus et al., STANDARD VERSUS ALTERNATING NON-CROSS-RESISTANT CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER - AN EORTC PHASE-III TRIAL, European journal of cancer, 32A(9), 1996, pp. 1498-1503
RESULTS OF A PHASE-II TRIAL OF EPIRUBICIN AND CISPLATIN (EP) BEFORE AND AFTER IRRADIATION AND 5-FLUOROURACIL IN LOCALLY ADVANCED PANCREATIC-CANCER - AN EORTC GITCCG STUDY
Authors: WAGENER DJT HOOGENRAAD WJ ROUGIER P LUSINCHI A TAAL BG VEENHOF CHN DEGRAEFF A CONROY T CURRAN D SAHMOUD T WILS J
Citation: Djt. Wagener et al., RESULTS OF A PHASE-II TRIAL OF EPIRUBICIN AND CISPLATIN (EP) BEFORE AND AFTER IRRADIATION AND 5-FLUOROURACIL IN LOCALLY ADVANCED PANCREATIC-CANCER - AN EORTC GITCCG STUDY, European journal of cancer, 32A(8), 1996, pp. 1310-1313
GENITOURINARY GROUP PHASE-II STUDY OF CHEMOTHERAPY IN STAGE T3-4 N0-XM0 TRANSITIONAL-CELL CANCER OF THE BLADDER - PROGNOSTIC FACTOR-ANALYSIS
Authors: SPLINTER TAW PAVONEMACALUSO M JACQMIN D ROBERTS JT CARPENTIER P DEPAUW M SAHMOUD T
Citation: Taw. Splinter et al., GENITOURINARY GROUP PHASE-II STUDY OF CHEMOTHERAPY IN STAGE T3-4 N0-XM0 TRANSITIONAL-CELL CANCER OF THE BLADDER - PROGNOSTIC FACTOR-ANALYSIS, European journal of cancer, 32A(7), 1996, pp. 1129-1134
TREATMENT OF RECURRENT MALIGNANT SUPRATENTORIAL GLIOMAS WITH IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE - A PHASE-II STUDY
Authors: SANSON M AMERI A MONJOUR A SAHMOUD T RONCHIN P POISSON M DELATTRE JY
Citation: M. Sanson et al., TREATMENT OF RECURRENT MALIGNANT SUPRATENTORIAL GLIOMAS WITH IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE - A PHASE-II STUDY, European journal of cancer, 32A(13), 1996, pp. 2229-2235
CHARACTERIZATION OF COMPLETE RESPONDERS TO COMBINATION CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A RETROSPECTIVE EORTC BREAST GROUP-STUDY
Authors: TOMIAK E PICCART M MIGNOLET F SAHMOUD T PARIDAENS R NOOY M BEEX L FENTIMAN IS MULLER A VANDERSCHUEREN E RUBENS RD
Citation: E. Tomiak et al., CHARACTERIZATION OF COMPLETE RESPONDERS TO COMBINATION CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A RETROSPECTIVE EORTC BREAST GROUP-STUDY, European journal of cancer, 32A(11), 1996, pp. 1876-1887
Risultati: 1-25 | 26-48